>Pluristem is one of the companies focusing on the commercial development of stem cells. There are two or three names which have been regularly sending out press releases concerning their research and development (besides ACT, of course). In this case, it’s a company that’s marketing selected umbilical cord blood cells or placental cells. If the … Continue reading
Pluristem is one of the companies focusing on the commercial development of stem cells. There are two or three names which have been regularly sending out press releases concerning their research and development (besides ACT, of course). In this case, it’s a company that’s marketing selected umbilical cord blood cells or placental cells. If the … Continue reading